Forensic Science International Supplement Series
Volume 1, Issue 1 , Pages 29-32 , December 2009

The toxicological challenges in the European research project DRUID

  • Kristof Pil

      Affiliations

    • Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, De Pintelaan 185, 9000 Ghent, Belgium
    • ,
  • Elke Raes

      Affiliations

    • Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, De Pintelaan 185, 9000 Ghent, Belgium
    • ,
  • Alain G. Verstraete

      Affiliations

    • Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, De Pintelaan 185, 9000 Ghent, Belgium
    • Laboratory of Clinical Chemistry-Toxicology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
    • Corresponding Author InformationCorresponding author at: Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Policlinic 8, 2nd floor, De Pintelaan 185, 9000 Ghent, Belgium. Tel.: +32 9 332 34 07; fax: +32 9 332 49 85.

Received 21 July 2009 ,Accepted 2 August 2009.

References 

  1. Bernhoft IM, Hels T, Assum T, Mathijssen R, Verstraete A. Protocols for road side surveys and hospital studies. Proceedings of the 45th International Meeting of the International Association of Forensic Toxicologists. Seattle, USA, August 26–30, 2007, Ann. Toxicol. Anal. 2007;4:310–311
  2. Verstraete A, Raes E. Rosita-2 Project—Final Report. Gent: Academia Press; 2006;
  3. SAMHSA . Proposed guidelines for mandatory drug testing. Fed. Regist. 2004;69:19673–19731
  4. Walsh M, Verstraete A, Huestis M, Morland J. Guidelines for research on drugged driving. Addiction. 2008;103:1258–1268
  5. Skopp G, Klingmann A, Pötsch L, Mattern R. In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte. Ther. Drug Monitor. 2001;23:174–181
  6. Crouch D. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int. 2005;150:165–173
  7. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing in oral fluid—evaluation of sample collection devices. J. Anal. Toxicol. 2008;32:1–9
  8. Concheiro M, de Castro A, Quintela O, Cruz A, López-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bional. Chem. 2008;391:2329–2338
  9. Oiestad E, Johansen U, Christopherson A. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2007;53:300–309
  10. Gunnar T, Mykkänen S, Ariniemi K, Lillsunde P. Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004;806:205–219
  11. Kankaanpää A, Gunnar T, Ariniemi K, Lillsunde P, Mykkänen S, Seppälä T. Single-step procedure for gas chromatography–mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004;810:57–68
  12. Pil K, Raes E, Verstraete A. Preliminary method for the simultaneous quantification of psychoactive substances in oral fluid using UPLC–MS–MS. Proceedings of the 46th International Meeting of the International Association of Forensic Toxicologists. Martinique, June 2–8, 2008, Ann. Toxicol. Anal. 2008;20(Suppl. 1):22
  13. Lechowicz W, Kala M, Walker J. Screening and quantification of the twenty-four drugs in oral fluid relevant or road traffic safety by means of liquid chromatography tandem mass spectrometry with electrospray ionization. Proceedings of the 45th International Meeting of the International Association of Forensic Toxicologists. Seattle, USA, August 26–30, 2007, Ann. Toxicol. Anal. 2007;19:324
  14. Clarke J, Wilson JF. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci. Int. 2005;150:161–164
  15. Stout P, Ropero-Miller J, Eicheldinger C, Dale Hart E, Baylor M, Mitchell J. Results of a pilot oral fluids performance testing program in the United States. Proceedings of the 45th International Meeting of the International Association of Forensic Toxicologists. Seattle, USA, August 26–30, 2007, Ann. Toxicol. Anal. 2007;19:320–321
  16. Ventura M, Ventura R, Pichini S, Leal S, Zuccaro P, Pacifici R, et al. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid. Results obtained in the first round performed in 2007. Proceedings of the 46th International Meeting of the International Association of Forensic Toxicologists. Martinique, June 2–8, 2008, Ann. Toxicol. Anal. 2008;20(Suppl. 1):39
  17. Kauert G, Ramaekers J, Schneider E, Moeller M, Toennes S. Pharmacokinetic properties of delta(9)-tetrahydrocannabinol in serum and oral fluid. J. Anal. Toxicol. 2007;31:288–293
  18. Drummer O. Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci. Int. 2005;150:133–142
  19. Engblom C, Gunnar T, Rantanen A, Lillsunde P. Driving under the influence of drugs—amphetamine concentrations in oral fluid and whole blood samples. J. Anal. Toxicol. 2007;31:276–280
  20. Huestis M, Cone E. Methamphetamine disposition in oral fluid, plasma, and urine. Ann. N. Y. Acad. Sci. 2007;1098:104–121
  21. Huestis M, Cone E. Relationship of delta(9)-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 2004;28:394–399

PII: S1875-1741(09)00013-5

doi: 10.1016/j.fsisup.2009.08.001

Forensic Science International Supplement Series
Volume 1, Issue 1 , Pages 29-32 , December 2009

Article Tools